Cargando…

microRNA Therapeutics in Cancer — An Emerging Concept

MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding RNAs that negatively regulate protein coding gene and other non-coding transcripts expression. miRNAs have been established as master regulators of cellular processes, and they play a vital role in tumor initiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Maitri Y., Ferrajoli, Alessandra, Sood, Anil K, Lopez-Berestein, Gabriel, Calin, George A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078622/ https://www.ncbi.nlm.nih.gov/pubmed/27720213 http://dx.doi.org/10.1016/j.ebiom.2016.09.017

Ejemplares similares

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
por: Shah, Maitri Y, et al.
Publicado: (2011)

MicroRNA and nephropathy: emerging concepts
por: Chung, Arthur CK, et al.
Publicado: (2013)

Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)

The involvement of microRNA in the pathogenesis of Richter syndrome
por: Van Roosbroeck, Katrien, et al.
Publicado: (2019)

Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
por: Bullock, Marc D., et al.
Publicado: (2015)

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

MicroRNA: an Emerging Therapeutic Target and Intervention Tool
por: Liu, Zhen, et al.
Publicado: (2008)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

MicroRNA‐124: An emerging therapeutic target in cancer
por: Jia, Xinqi, et al.
Publicado: (2019)

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2023)

Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2017)

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
por: Mokhlis, Hamada A., et al.
Publicado: (2018)

Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2023)

Principles of microRNA involvement in human cancers
por: Ling, Hui, et al.
Publicado: (2011)

MicroRNA Processing and Human Cancer
por: Ohtsuka, Masahisa, et al.
Publicado: (2015)

Breast cancer metastasis: a microRNA story
por: Negrini, Massimo, et al.
Publicado: (2008)

Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
por: Rozovski, Uri, et al.
Publicado: (2013)

miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022)

Using microRNA Networks to Understand Cancer
por: Dragomir, Mihnea, et al.
Publicado: (2018)

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
por: López Castel, Arturo, et al.
Publicado: (2019)

MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke
por: Kadir, Rais Reskiawan A., et al.
Publicado: (2020)

MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
por: Zhang, Wen-Hao, et al.
Publicado: (2023)

The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target
por: Sameti, Pouriya, et al.
Publicado: (2023)

MicroRNA therapeutics in cardiovascular medicine
por: Thum, Thomas
Publicado: (2012)

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013)

Catalog of MicroRNA Seed Polymorphisms in Vertebrates
por: Zorc, Minja, et al.
Publicado: (2012)

MicroRNA expression signature and the therapeutic effect of the microRNA-21 antagomir in hypertrophic scarring
por: Guo, Liang, et al.
Publicado: (2017)

MicroRNA based theranostics for brain cancer: basic principles
por: Petrescu, George E. D., et al.
Publicado: (2019)

The Emerging Role of MicroRNA-155 in Cardiovascular Diseases
por: Cao, Richard Y., et al.
Publicado: (2016)

PDGF induced microRNA alterations in cancer cells
por: Shao, Minghai, et al.
Publicado: (2011)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

The Expression of microRNA and microRNA Clusters in the Aging Heart
por: Zhang, Xiaomin, et al.
Publicado: (2012)

Development of microRNA therapeutics is coming of age
por: van Rooij, Eva, et al.
Publicado: (2014)

MicroRNA as therapeutic targets for treatment of depression
por: Hansen, Katelin F, et al.
Publicado: (2013)

Development of MicroRNA Therapeutics for Hepatocellular Carcinoma
por: Aravalli, Rajagopal N.
Publicado: (2013)

The Potential for microRNA Therapeutics and Clinical Research
por: Hanna, Johora, et al.
Publicado: (2019)

MicroRNAs in Myeloid Hematological Malignancies
por: Ciccone, Maria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oa3bjujuqrapm1900cc84ig3f2